Hyperbilirubinemia
A condition characterized by an abnormal increase of BILIRUBIN in the blood, which may result in JAUNDICE. Bilirubin, a breakdown product of HEME, is normally excreted in the BILE or further catabolized before excretion in the urine.
Subtype terms (3)
More specific conditions that are subtypes of Hyperbilirubinemia in the MeSH hierarchy.
- Hyperbilirubinemia, Neonatal
14 drugs (6 approved, 8 experimental)
- Jaundice
10 drugs (6 approved, 4 experimental)
- Kernicterus
1 drug approved
Drugs by status
Approved for this indication (1)
Phase 4 trials (3)
Phase 3 trials (2)
Other trials (2)
Organizations
Organization Involved with Phase 4 Indications (5)
Organization Involved with Phase 3 Indications (2)
Organization Involved with Phase 2 Indications (7)
Organization Involved with Phase 1 Indications (2)
Organization Involved with Other Experimental Indications (9)